Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from MedAdvisor Limited ( (AU:MDR) ) is now available.
MedAdvisor Limited has entered into a non-binding Letter of Intent with a subsidiary of a major multinational software company to sell its ANZ business division and associated intellectual property. The potential transaction, valued at $35 million with an additional earn-out component, could significantly impact MedAdvisor’s operations and market positioning by aligning with a company that has a substantial market capitalization and revenue.
More about MedAdvisor Limited
MedAdvisor Limited is a global company specializing in pharmacy-driven patient engagement. The company operates primarily in the ANZ region under the MedAdvisor brand, focusing on enhancing patient engagement through innovative software solutions.
Average Trading Volume: 647,395
Technical Sentiment Signal: Sell
Current Market Cap: A$59.77M
Learn more about MDR stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue